Organovo Holdings Inc (NASDAQ:ONVO)

1.69
Delayed Data
As of Feb 01
 +0.055 / +3.37%
Today’s Change
1.37
Today|||52-Week Range
4.67
+19.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.0M

Company Description

Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.

Contact Information

Organovo Holdings, Inc.
11555 Sorrento Valley Road
San Diego California 92121
P:(858) 224-1000
Investor Relations:
(858) 224-1092

Employees

Shareholders

Other institutional5.08%
Individual stakeholders2.34%
Mutual fund holders12.14%

Top Executives

Keith MurphyExecutive Chairman & Chief Executive Officer
Thomas P. HessChief Financial & Accounting Officer
Jeffrey N. MinerChief Scientific Officer
Curtis TyreeSenior VP-Strategy & Business Development
Steve E. KunszaboVP-Investor Relations & Corporate Communications